Riba Rocio, Sharifi Marzieh, Farndale Richard W, Naseem Khalid M
Department of Biomedical Sciences, University of Bradford, UK.
Thromb Haemost. 2005 Aug;94(2):395-403. doi: 10.1160/TH05-01-0027.
The molecular regulation of nitric oxide synthase (NOS) in blood platelets is an uncharacterised area of platelet biology. We investigated the mechanism of collagen-stimulated NO synthesis in platelets. Our aim was to identify the key collagen receptor and downstream signalling mechanisms linking collagen to NOS activation. Collagen and the GpVI-specific platelet activator collagen-related peptide (CRP-XL) stimulated NO synthesis, as evidenced by increased [(3)H]L-citrulline production, and cyclic GMP (cGMP) formation. After platelet activation by collagen and CRP-XL was normalised, we found no differences in NOS activation or cGMP formation in response to these agonists. Blocking the interaction of collagen with integrin alpha(2)beta(1), a second collagen receptor, failed to affect NOS activation by collagen. These data indicate that collagen-induced NO synthesis is linked to GpVI activation. cGMP formation in response to collagen and CRP-XL required increased intracellular Ca(2+), Src family kinases, phosphatidylinositol 3-kinase (PI3-K) and protein kinase C. By comparison, Gp VI-independent cGMP formation induced by thrombin was Src kinase-dependent, but was independent of PI3-K and PKC. Thus the mechanisms of collagen- and CRP-XL-induced NOS activation were identical, but distinct from that of thrombin. Platelet activation in response to collagen leads to secretion of adenosine diphosphate (ADP) and thromboxane A(2) (TxA(2)). Our results demonstrate that collagen-stimulated cGMP synthesis was enhanced significantly by platelet-derived ADP and TxA(2). These results reveal that collagen stimulates platelet NOS activation through a specific Ca(2+)-dependent GpVI receptor signalling cascade, and demonstrate that collagen-induced cGMP accrual requires the release of secondary platelet agonists.
血小板中一氧化氮合酶(NOS)的分子调控是血小板生物学中一个尚未明确的领域。我们研究了胶原蛋白刺激血小板中NO合成的机制。我们的目的是确定将胶原蛋白与NOS激活联系起来的关键胶原蛋白受体和下游信号传导机制。胶原蛋白和GpVI特异性血小板激活剂胶原蛋白相关肽(CRP-XL)刺激了NO合成,[(3)H]L-瓜氨酸生成增加和环鸟苷酸(cGMP)形成证明了这一点。在胶原蛋白和CRP-XL引起的血小板激活正常化后,我们发现这些激动剂刺激下的NOS激活或cGMP形成没有差异。阻断胶原蛋白与整合素α(2)β(1)(另一种胶原蛋白受体)的相互作用未能影响胶原蛋白对NOS的激活。这些数据表明,胶原蛋白诱导的NO合成与GpVI激活有关。响应胶原蛋白和CRP-XL的cGMP形成需要细胞内Ca(2+)、Src家族激酶、磷脂酰肌醇3激酶(PI3-K)和蛋白激酶C增加。相比之下,凝血酶诱导的不依赖Gp VI的cGMP形成依赖于Src激酶,但不依赖于PI3-K和PKC。因此,胶原蛋白和CRP-XL诱导的NOS激活机制相同,但与凝血酶的机制不同。响应胶原蛋白的血小板激活导致二磷酸腺苷(ADP)和血栓素A(2)(TxA(2))的分泌。我们的结果表明,血小板衍生的ADP和TxA(2)显著增强了胶原蛋白刺激的cGMP合成。这些结果表明,胶原蛋白通过特定的Ca(2+)依赖性GpVI受体信号级联刺激血小板NOS激活,并证明胶原蛋白诱导的cGMP积累需要释放次级血小板激动剂。